Intercept Pharmaceuticals, Inc.
TGR5 modulators and methods of use thereof
Last updated:
Abstract:
The application relates to compounds of formula A: ##STR00001## or a salt, solvate, ester, tautomer, amino acid conjugate, or metabolite thereof. The compounds of formula A are TGR5 modulators useful for the treatment of various diseases, including metabolic disease, inflammatory disease, autoimmune disease, cardiac disease, kidney disease, cancer, and gastrointestinal disease.
Status:
Grant
Type:
Utility
Filling date:
2 Sep 2020
Issue date:
31 May 2022